Cianferotti, Luisella
Parri, Simone
Gronchi, Giorgio
Marcucci, Gemma
Cipriani, Cristiana
Pepe, Jessica
Raglianti, Marco
Minisola, Salvatore
Brandi, Maria Luisa http://orcid.org/0000-0002-8741-0592
Funding for this research was provided by:
Shire (IIR-ITA-001135)
Article History
Received: 29 November 2017
Accepted: 9 February 2018
First Online: 8 March 2018
Compliance with Ethical Standards
:
: S.M. has served as speaker for Abiogen, Amgen, Bruno Farmaceutici, Diasorin, Eli Lilly, Italfarmaco, Fujii, Merck Sharp & Dohme, Takeda. He has also served in the advisory board of Amgen, Eli Lilly and Merck Sharp & Dohme and received consultancy fees from Bruno Farmaceutici. M.L.B. has received consultancy fees and grant support from Alexion, Abiogen, Amgen, Eli Lilly, and Shire. L.C., S.P., G.G., G.M., C.C., J.P., and M.R., have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.